268 related articles for article (PubMed ID: 28105491)
1. The multi-faceted role of retinoid X receptor in bone remodeling.
Menéndez-Gutiérrez MP; Ricote M
Cell Mol Life Sci; 2017 Jun; 74(12):2135-2149. PubMed ID: 28105491
[TBL] [Abstract][Full Text] [Related]
2. Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.
Menéndez-Gutiérrez MP; Rőszer T; Fuentes L; Núñez V; Escolano A; Redondo JM; De Clerck N; Metzger D; Valledor AF; Ricote M
J Clin Invest; 2015 Feb; 125(2):809-23. PubMed ID: 25574839
[TBL] [Abstract][Full Text] [Related]
3. Ligand Design for Modulation of RXR Functions.
Martínez C; Souto JA; de Lera AR
Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
[TBL] [Abstract][Full Text] [Related]
4. Retinoid X receptors in macrophage biology.
Rőszer T; Menéndez-Gutiérrez MP; Cedenilla M; Ricote M
Trends Endocrinol Metab; 2013 Sep; 24(9):460-8. PubMed ID: 23701753
[TBL] [Abstract][Full Text] [Related]
5. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
6. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
7. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
Ahuja HS; Szanto A; Nagy L; Davies PJ
J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
[TBL] [Abstract][Full Text] [Related]
8. RXRs: collegial partners.
Gilardi F; Desvergne B
Subcell Biochem; 2014; 70():75-102. PubMed ID: 24962882
[TBL] [Abstract][Full Text] [Related]
9. Natural ligands of RXR receptors.
García P; Lorenzo P; de Lera AR
Methods Enzymol; 2020; 637():209-234. PubMed ID: 32359646
[TBL] [Abstract][Full Text] [Related]
10. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
Dominguez M; Alvarez S; de Lera AR
Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
[TBL] [Abstract][Full Text] [Related]
11. RXR heterodimers orchestrate transcriptional control of neurogenesis and cell fate specification.
Simandi Z; Horvath A; Cuaranta-Monroy I; Sauer S; Deleuze JF; Nagy L
Mol Cell Endocrinol; 2018 Aug; 471():51-62. PubMed ID: 28778663
[TBL] [Abstract][Full Text] [Related]
12. A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation.
Morichika D; Miyahara N; Fujii U; Taniguchi A; Oda N; Senoo S; Kataoka M; Tanimoto M; Kakuta H; Kiura K; Maeda Y; Kanehiro A
Respir Res; 2019 Jan; 20(1):2. PubMed ID: 30606200
[TBL] [Abstract][Full Text] [Related]
13. The multi-faceted role of retinoid X receptor in cardiovascular diseases.
Shao M; Lu L; Wang Q; Ma L; Tian X; Li C; Li C; Guo D; Wang Q; Wang W; Wang Y
Biomed Pharmacother; 2021 May; 137():111264. PubMed ID: 33761589
[TBL] [Abstract][Full Text] [Related]
14. Retinoid X receptors: common heterodimerization partners with distinct functions.
Lefebvre P; Benomar Y; Staels B
Trends Endocrinol Metab; 2010 Nov; 21(11):676-83. PubMed ID: 20674387
[TBL] [Abstract][Full Text] [Related]
15. Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR-RXR heterodimers to confer ligand-dependent activation of hRAR beta 2/RARE (DR5).
Xiao JH; Durand B; Chambon P; Voorhees JJ
J Biol Chem; 1995 Feb; 270(7):3001-11. PubMed ID: 7852380
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
[TBL] [Abstract][Full Text] [Related]
17. Retinoid X receptor ligands: a patent review (2007 - 2013).
Yamada S; Kakuta H
Expert Opin Ther Pat; 2014 Apr; 24(4):443-52. PubMed ID: 24456080
[TBL] [Abstract][Full Text] [Related]
18. Alternative retinoid X receptor (RXR) ligands.
Krężel W; Rühl R; de Lera AR
Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking, dynamics, and pharmacology studies on bexarotene as an agonist of ligand-activated transcription factors, retinoid X receptors.
Chitranshi N; Dheer Y; Kumar S; Graham SL; Gupta V
J Cell Biochem; 2019 Jul; 120(7):11745-11760. PubMed ID: 30746761
[TBL] [Abstract][Full Text] [Related]
20. Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cells.
Lehman AM; Montford JR; Horita H; Ostriker AC; Weiser-Evans MC; Nemenoff RA; Furgeson SB
Mol Pharmacol; 2014 Nov; 86(5):570-9. PubMed ID: 25169989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
